Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CORVUS PHARMACEUTICALS, INC.

(CRVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart CORVUS PHARMACEUTICALS, INC.
Upcoming events on CORVUS PHARMACEUTICALS, INC.
03/10/22 FY 2021 Earnings Release (Projected)
05/05/22 Q1 2022 Earnings Release (Projected)
08/04/22 Interim 2022 Earnings Release (Projected)
11/03/22 Q3 2022 Earnings Release (Projected)
Past events on CORVUS PHARMACEUTICALS, INC.
11/18/21 | 03:00am Jefferies London Healthcare Conference
11/12/21 | 09:00am Society for Immunotherapy of Cancer Meeting
11/12/21 | 07:00am Society for immunotherapy of cancer meeting - poster #: 01
11/01/21 | 03:05pm Q3 2021 Earnings Release
09/29/21 | 03:20pm Cantor Fitzgerald Global Healthcare Conference
09/13/21 | 07:00am H.C. Wainwright Global Investment Conference
08/02/21 | 04:05pm Interim 2021 Earnings Release
07/15/21 | 04:30pm Business Update Call
06/15/21 | 04:00pm Annual General Meeting
06/03/21 | 04:00pm Jefferies Healthcare Conference
Past dividends on CORVUS PHARMACEUTICALS, INC.

- No events available -

Annual results
Fiscal Period : December201620172018201920202021
Sales
M $
Released
Forecast
Spread
-35,7
-34,8
-2,8%
-55,9
-61,5
9,1%
-49,0
-55,4
12%


 


 
 

 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-37,0
-37,7
1,8%
-56,5
-60,2
6,1%
-49,2
-52,0
5,4%
-48,9
-50,0
2,2%
-43,8
-43,7
-0,12%
 
-41,3
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-36,4
-36,8
1,1%
-55,7
-59,6
6,6%
-46,9
-49,9
6,0%
-46,7
-46,9
0,52%
-6,00
-56,9
89%
 
-42,9
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-36,4
-36,7
0,80%
-55,7
-59,6
6,6%
-46,9
-50,0
6,2%
-46,7
-46,9
0,52%
-6,00
-41,0
85%
 
-42,9
 
Net income
$
Released
Forecast
Spread
-2,36
-2,14
-10%
-2,72
-2,89
5,9%
-1,71
-1,83
6,8%
-1,59
-1,57
-1,6%
-0,20
-1,39
86%
 
-0,98
 
Announcement Date03/10/201703/01/201803/07/201903/05/202003/25/2021-
Quarterly results
Fiscal Period : December2020 Q32020 Q42021 Q12021 Q22021 Q32021 Q4
Sales
M $
Released
Forecast
Spread
-9,85
-7,63
-29%
-9,88
-9,82
-0,58%
-11,5
-12,1
5,3%
-11,3
-12,2
7,3%
-9,05
-10,1
10%
 
-9,55
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-9,80
-7,53
-30%
27,3
-41,0
167%


 
-11,8
-11,5
-1,8%
-10,7
-8,95
-19%
 
-8,86
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-9,80
-7,53
-30%
27,3
-7,10
485%


 
-11,8
-11,5
-1,8%
-10,7
-8,95
-19%
 
-8,86
 
Pre-Tax Profit
(EBT)
$
Released
Forecast
Spread
-0,33
-0,27
-24%
0,93
-0,24
488%
-0,34
-0,30
-13%
-0,28
-0,29
1,8%
-0,24
-0,21
-14%
 
-0,19
 
Announcement Date10/29/202003/25/202104/29/202108/02/202111/01/2021-
Previous year Next Year
Upcoming sector events for CORVUS PHARMACEUTICALS, INC.
More events
Past sector events for CORVUS PHARMACEUTICALS, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise